Men age 40 and older with overactive bladder symptoms that have not been controlled by alpha-blocker treatment alone are invited to participate in a University of Iowa research study.
The study focuses on whether an investigational medicine can reduce urinary frequency, urgency and/or incontinence when added to existing alpha-blocker treatment. Men with a history of interstitial cystitis or prostate cancer are not eligible to participate.
The study will involve approximately five visits to UI Hospitals and Clinics over 13 weeks. Participants will randomly be assigned to take the active study medication or the placebo in addition to their currently prescribed alpha-blocker. Study drug and any related tests will be provided at no cost. Compensation for clinic visits and parking is also available.
For more information about participating in this study contact the study coordinator Mary Eno at 319-384-9265 or email@example.com.